Project Grant R01DA062557
- This $554,922 Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to explore the role of harm reduction vending machines (Project HOPE) in reducing the risk of HIV infection and transmission among people who use drugs (PWUDs). The key objectives are to: 1) Determine the effects of Project HOPE on HIV screening behaviors, 2) Assess whether the program improves access to HIV self-testing kits and...
- This Project Grant award of $2,332,500.00 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to transform systems of care in Washington state prisons to better address HIV, HIV risk, and substance use disorders. The key products and services to be delivered include: Building the foundation for a "prison learning health system" to improve the quality, efficiency, and reach of HIV treatment, HIV prevention, and...
- This federal Project Grant award for $896,804, provided by the National Institute on Drug Abuse (NIDA) through the Drug Use and Addiction Research Programs (CFDA 93.279), aims to develop a cost-based epidemiological planning tool to address the combined HIV, HCV, and opioid use disorder epidemics. The key products and services to be delivered under this award are: 1) Development of an interactive, web-based dashboard that can assist policymakers in planning an effective multi-pronged response to...
- The National Institute on Drug Abuse (NIDA) awarded a $569,743 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Yale University on July 15, 2025. The grant, titled "Y-SCORCH 2.0: Further Data Mining and Functional Characterization for Single Cell Opioid Responses in the Context of HIV (SCORCH) Program," aims to leverage advanced tools to analyze transcriptomic and epigenetic data from the SCORCH consortium and novel spatial transcriptomic data to...
- This federal Project Grant award from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), under the Drug Use and Addiction Research Programs (CFDA 93.279), will fund a study to optimize opioid use disorder (OUD) treatment in prisons. The key products and services to be delivered include: Validating a 2-item OUD screening tool and an 11-item diagnostic DSM-5 OUD symptom checklist adapted for use in prisons. This will involve validating these tools against...
- This Project Grant award of $722,917 from the National Institute on Drug Abuse (NIDA), part of the Department of Health and Human Services, will fund a 5-year study to evaluate a new approach for dispensing methadone to incarcerated individuals with opioid use disorder (OUD) in three state prison systems. The project aims to support widespread implementation of the hospital/clinic designation, which allows carceral facilities to stock and dispense methadone for OUD treatment, by launching a...
- This Project Grant award of $783,300 from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) will fund a research study titled "Informing Best Practices for Substance-Use Treatment with Real-World Evidence for People with Opioid Use Disorder and HIV (STRONG)". The study will be conducted by The Johns Hopkins University in Maryland and aims to comprehensively characterize opioid use disorder (OUD) treatment, co-occurring substance use and...
- This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $187,023 to Baystate Medical Center, Inc. in Massachusetts. The purpose is to conduct a mixed-methods study to determine the impact of the state's Behavioral Health Supports for Justice-Involved Individuals (BH-JI) program on healthcare utilization, costs, and overdose outcomes for individuals with opioid use disorder (OUD) upon release from...
- This $375,000 federal Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) aims to evaluate the impact of a status-neutral, person-centric intervention called the "Blue Shed" on HIV transmission and outcomes among people who inject drugs (PWID) in New Delhi, India. The project has three key objectives: Assess the direct impact of the Blue Shed intervention on HIV incidence, viral suppression, and mortality among PWID...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $677,250 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of Miami. The grant, awarded on June 15, 2025, supports the development and testing of the "Healthcare Empowerment and Advocacy for Recovery from Trafficking (HEART) Intervention" for implementation in syringe service programs. The project aims to engage women with experiences of...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $775,550 to Yale University to conduct a cluster randomized controlled trial of the HOPE (Help OAT Prison Engagement) intervention. HOPE is a 6-week program tailored to the high-risk prison environment in Kyrgyzstan, with the goal of increasing uptake of opioid agonist therapy (OAT) and syringe service programs (SSP) to prevent HIV in this population. The intervention incorporates HIV screening, mental health assessment and enhancement, addiction literacy, and skills-building to address barriers such as stigma. Over 12 months, the study will enroll 360 participants across 20 housing units in 4 male prisons in Kyrgyzstan to evaluate the effectiveness of HOPE for HIV prevention. The award commenced on August 15, 2025 and is expected to be completed by May 31, 2030.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $33.8k | 9/5/25 | ||
| Not listed | $137.1k | 8/19/25 | ||
| Not listed | $86.3k | 8/19/25 | ||
| Not listed | $518.4k | 8/8/25 |